We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£595.00
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Japan
Price data last checked 24 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£595 today · cheaper than every other day in the last 3 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 67 days • 67 data points (No recent data available)
Price Distribution
Price distribution over 67 days • 1 price levels
Price Analysis
Most common price: £595 (67 days, 100.0%)
Price range: £595 - £595
Price levels: 1 different prices over 67 days
Product Specifications
- Format
- paperback
- ASIN
- B01575IO6O
- Domain
- Amazon UK
- Release Date
- 28 August 2015
- Listed Since
- 10 September 2015
Similar Products You Might Like
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in India
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Greater China
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in the United States
The 2016 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in North America & the Caribbean
The 2016-2021 Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products in Africa
The 2023 Report on Therapeutic Monoclonal Antibody (Mab)-Based Products: World Market Segmentation by City
The 2025-2030 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
The 2023-2028 World Outlook for Custom Antibodies
Therapeutic Monoclonal Antibodies: From Lot Release to Stability Testing
Academic Press
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2021-2026 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
The 2026-2031 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
The 2025-2030 World Outlook for Custom Antibodies
The 2016-2021 Outlook for Media Advertising in Japan
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in Greater China
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in India
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
The 2026-2031 World Outlook for Antibodies
